Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection

International Journal of Antimicrobial Agents

Volumn 35, Issue 2, 2010, Pages 152-155

  Ruíz Cendoya, Mery ^a   Madrid, Hugo ^a   Pastor, Javier ^a   Guarro, Josep ^a  

^a INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

Author keywords

Murine infection; Neoscytalidium; Therapy

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FUNGIZONA; POSACONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; FUNGAL STRAIN; FUNGUS; FUNGUS GROWTH; HISTOPATHOLOGY; KIDNEY PARENCHYMA; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; MYCOSIS; NEOSCYTALIDIUM DIMIDIATUM; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SURVIVAL TIME;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ASCOMYCOTA; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; KIDNEY; MALE; MICE; MYCOSES; NEUTROPENIA; PYRIMIDINES; SEPSIS; SPLEEN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRIAZOLES;

EID: 72449155184     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.09.028     Document Type: Article

References (16)

1. Ungpakorn R., Lohaprathan S., and Reangchainam S. Prevalence of foot diseases in outpatients attending the Institute of Dermatology, Bangkok, Thailand. Clin Exp Dermatol 29 (2004) 87-90
2. Barua P., Barua S., Borkakoty B., and Mahanta J. Onychomycosis by Scytalidium dimidiatum in green tea leaf pluckers: report of two cases. Mycopathologia 164 (2007) 193-195
3. Elinav H., Izhar U., Benenson S., Admon D., Hidalgo-Grass C., Polacheck I., et al. Invasive Scytalidium dimidiatum infection in an immunocompetent adult. J Clin Microbiol 47 (2009) 1259-1263
4. Mani R.S., Chickabasaviah Y.T., Nagarathna S., Chandramuki A., Shivprakash M.R., Vijayan J., et al. Cerebral phaeohyphomycosis caused by Scytalidium dimidiatum: a case report from India. Med Mycol 46 (2008) 705-711
5. Tan D.H., Sigler L., Gibas C.F., and Fong I.W. Disseminated fungal infection in a renal transplant patient involving Macrophomina phaseolina and Scytalidium dimidiatum: case report and review of taxonomic changes among medically important members of the Botryosphaeriaceae. Med Mycol 46 (2008) 285-292
6. Morris-Jones R., Youngchim S., Hextall J.M., Gomez B.L., Morris-Jones S.D., Hay R.J., et al. Scytalidium dimidiatum causing recalcitrant subcutaneous lesions produces melanin. J Clin Microbiol 42 (2004) 3789-3794
7. Dunn J.J., Wolfe M.J., Trachtenberg J., Kriesel J.D., Orlandi R.R., and Carroll K.C. Invasive fungal sinusitis caused by Scytalidium dimidiatum in a lung transplant recipient. J Clin Microbiol 41 (2003) 5817-5819
8. Geramishoar M., Zomorodian K., Zaini F., Saadat F., Tarazooie B., Norouzi M., et al. First case of cerebral phaeohyphomycosis caused by Nattrassia mangiferae in Iran. Jpn J Infect Dis 57 (2004) 285-286
9. Willinger B., Kopetzky G., Harm F., Apfalter P., Makristathis A., Berer A., et al. Disseminated infection with Nattrassia mangiferae in an immunosuppressed patient. J Clin Microbiol 42 (2004) 478-480
10. Madrid H., Ruíz-Cendoya M., Cano J., Stchigel A., Orofino R., and Guarro J. Genotyping and in vitro antifungal susceptibility of Neoscytalidium dimidiatum isolates from different origins. Int J Antimicrob Agents 34 (2009) 351-354
11. Lacroix C., and de Chauvin M.F. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates. J Antimicrob Chemother 61 (2008) 835-837
12. Sigler L., Summerbell R.C., Poole L., Wieden M., Sutton D.A., Rinaldi M.G., et al. Invasive Nattrassia mangiferae infections: case report, literature review, and therapeutic and taxonomic appraisal. J Clin Microbiol 35 (1997) 433-440
13. Benne C.A., Neelman C., Bruin M., de Hoog G.S., and Fleer A. Disseminating infection with Scytalidium dimidiatum in a granulocytopenic child. Eur J Clin Microbiol Infect Dis 12 (1993) 118-121
14. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard. 2nd ed. Document M38-A2. Wayne, PA: CLSI; 2008.
15. Sun Q., Najvar L., Bocanegra R., Loebenberg D., and Graybill J.R. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 46 (2002) 2310-2312
16. Clemons K.V., Espiritu M., Parmar R., and Stevens D.A. Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrob Agents Chemother 49 (2005) 4867-4875